Literature DB >> 8635650

LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation.

A J Jenkins1, R L Klein, C N Chassereau, K L Hermayer, M F Lopes-Virella.   

Abstract

Increased susceptibility of LDL to oxidation has been shown to be associated with the presence of coronary heart disease and may account for the accelerated vascular disease seen in diabetes. The response of LDL to in vitro oxidative stress has been proposed as a measure of the predisposition of LDL to the in vivo subendothelial oxidative stress. Increased susceptibility to oxidation has been demonstrated recently in diabetic patients with poorly controlled IDDM. Thus, we conducted studies to determine whether the increased susceptibility of LDL to oxidation was secondary to diabetes per se or to the level of glycemic control. Fifteen IDDM patients with good glycemic control and with no evidence of macrovascular disease or proteinuria were compared with healthy age-, sex-, race-, and BMI-matched nondiabetic subjects. Fasting blood glucose levels averaged 12.1 +/- 1.1 (mean +/- SE) vs. 4.9 +/- 0.1 mmol/l in the diabetic versus the control groups, respectively. HbA1c levels averaged 7.7 +/- 0.5 vs. 4.4 +/- 0.2%, reflecting well-controlled diabetes (P < 0.0001). Total, LDL, VLDL, and HDL cholesterol, triglyceride, and lipoprotein(a) levels did not differ between the groups. The particle size, lipid composition, fatty acid content, antioxidant content, and glycation were similar for LDL isolated from both groups. A rapid LDL preparation technique was used to compare LDL susceptibility to oxidation under the following conditions: final LDL cholesterol concentration of 100 microg/ml, 5 micromol/l of CuCl2 at 25 degrees C. There was no difference in the susceptibility to in vitro oxidation of LDL isolated from IDDM patients compared with control subjects. There was no correlation of glycemic control with any of the parameters of the in vitro oxidation of LDL. LDL from patients with well-controlled IDDM does not differ in composition or in susceptibility to in vitro oxidative stress compared with LDL from nondiabetic subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635650     DOI: 10.2337/diab.45.6.762

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

1.  Liver X receptor activation stimulates iron export in human alternative macrophages.

Authors:  Gaël Bories; Sophie Colin; Jonathan Vanhoutte; Bruno Derudas; Corinne Copin; Mélanie Fanchon; Mehdi Daoudi; Loïc Belloy; Stephan Haulon; Christophe Zawadzki; Brigitte Jude; Bart Staels; Giulia Chinetti-Gbaguidi
Journal:  Circ Res       Date:  2013-09-13       Impact factor: 17.367

2.  Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study.

Authors:  Arpita Basu; Petar Alaupovic; Mingyuan Wu; Alicia J Jenkins; Yongxin Yu; Alison J Nankervis; Kristian F Hanssen; Hanne Scholz; Tore Henriksen; Bjørg Lorentzen; Torun Clausen; Satish K Garg; M Kathryn Menard; Samar M Hammad; James A Scardo; John R Stanley; Azar Dashti; Christopher E Aston; Timothy J Lyons
Journal:  J Clin Endocrinol Metab       Date:  2012-03-21       Impact factor: 5.958

3.  The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity.

Authors:  J L Sánchez-Quesada; S Benítez; A Pérez; A M Wagner; M Rigla; G Carreras; L Vila; M Camacho; R Arcelus; J Ordóñez-Llanos
Journal:  Diabetologia       Date:  2005-08-18       Impact factor: 10.122

Review 4.  Diabetes, oxidative stress and physical exercise.

Authors:  Mustafa Atalay; David E Laaksonen
Journal:  J Sports Sci Med       Date:  2002-03-04       Impact factor: 2.988

Review 5.  Diabetic dyslipidaemia: current treatment recommendations.

Authors:  J D Best; D N O'Neal
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

6.  Association of postprandial hyperglycemia with in vitro LDL oxidation in non-smoking patients with type 1 diabetes--a cross-sectional study.

Authors:  Simone H de Castro; Hugo C Castro-Faria-Neto; Marilia B Gomes
Journal:  Rev Diabet Stud       Date:  2005-11-10

7.  Biphasic effect of Solanum nigrum fruit aqueous extract on vascular mesenteric beds in non-diabetic and streptozotocin-induced diabetic rats.

Authors:  Shahla Sohrabipour; Fatemah Kharazmi; Nepton Soltani; Mohammad Kamalinejad
Journal:  Pharmacognosy Res       Date:  2014-04

8.  Blood viscosity, lipid profile, and lipid peroxidation in type-1 diabetic patients with good and poor glycemic control.

Authors:  Neetu Mishra; Neelima Singh
Journal:  N Am J Med Sci       Date:  2013-09

9.  Changes in oxidant-antioxidant status in young diabetic patients from clinical onset onwards.

Authors:  P Martín-Gallán; A Carrascosa; M Gussinyé; C Domínguez
Journal:  J Cell Mol Med       Date:  2007 Nov-Dec       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.